白血球除去療法の世界市場レポート 2025年

白血球除去療法の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.9％で978億3,000万米ドルに成長します。この予測期間における成長は、個別化細胞治療に対する需要の高まり、免疫腫瘍学における臨床試験の増加、再生医療における採用の拡大、バイオ医薬品製造の拡大、償還政策の改善、細胞を用いた研究や治療オプションに対する認知度の向上などが牽引するとみられます。予測期間における主な動向としては、細胞分離技術の発展、手順の最適化のためのAIの統合、ポータブル白血球除去療法デバイスの開発、細胞・遺伝子治療の進歩、ドナースクリーニング方法の強化、クラウドベースのデータ追跡システムの採用などが挙げられます。

自己免疫疾患の罹患率の増加は、白血球除去療法市場の拡大を促進すると予想されています。自己免疫疾患は、免疫系が誤って身体の健康な組織を攻撃することで発生します。幼少期の微生物曝露の減少や現代環境の影響などの要因が免疫バランスを崩し、自己免疫疾患の増加をもたらしています。白血球除去療法は、免疫系による身体への攻撃を助長する有害な白血球を選択的に除去することで、これらの疾患の治療に役立ちます。例えば、ドイツを拠点とする団体Versorgungsatlas.deの報告によると、2022年には、7,324万1,305人の被保険者のうち、630万4,340人が少なくとも1つの自己免疫疾患と診断され、有病率は8.61％となりました。このように、自己免疫疾患の増加が白血球除去療法市場の成長を促進しています。

白血球除去療法市場の主要企業は、細胞治療製造の品質と効率を向上させるため、GMPグレードのロイコパックの開発などのイノベーションに注力しています。GMPグレードのロイコパックは、厳格な適正製造規範（GMP）基準の下で加工された白血球除去療法由来の製品であり、治療使用のための高い細胞生存率と機能性を保証します。例えば、米国を拠点とするバイオテクノロジー企業Sanguine Biosciences社は、2024年11月、ワークフローを合理化し、細胞治療開発をスピードアップするためにデザインされたGMPグレードのロイコパック、LeukoCerを発表しました。LeukoCerは、厳格なGMP基準に従って製造された高品質の出発材料を新鮮なホールパックまたはハーフパックで提供し、研究者が研究を進め、新しい細胞療法の市場導入を加速することを可能にします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の白血球除去療法のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の白血球除去療法市場：成長率分析
• 世界の白血球除去療法市場の実績：規模と成長、2019～2024年
• 世界の白血球除去療法市場の予測：規模と成長、2024～2029年、2034年
• 世界の白血球除去療法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の白血球除去療法市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 顆粒球アフェレーシス
• リンパ球アフェレーシス
• 単球アフェレーシス
• 世界の白血球除去療法市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 白血球除去療法装置
• 遠心装置
• 膜分離器
• 白血球除去療法使い捨て製品
• 世界の白血球除去療法市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 研究への応用
• がん研究
• 免疫研究
• 治療への応用
• 血液疾患
• 自己免疫疾患
• その他
• 世界の白血球除去療法市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 血液成分供給業者・血液センター
• 学術研究機関
• 製薬・バイオテクノロジー企業
• 病院・輸血センター
• 世界の白血球除去療法市場：顆粒球成分分析のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 好中球成分分析
• 好酸球成分分析
• 好塩基球成分分析
• 世界の白血球除去療法市場：リンパ球成分分析のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• T細胞成分分析
• B細胞成分分析
• ナチュラルキラー（NK）細胞成分分析
• 世界の白血球除去療法市場：単球成分分析のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 古典的単球
• 非古典的単球
• 中間単球

第7章 地域別・国別分析

• 世界の白血球除去療法市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の白血球除去療法市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 白血球除去療法市場：競合情勢
• 白血球除去療法市場：企業プロファイル
  • Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
  • Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Terumo BCT Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Nikkiso Co. Overview, Products and Services, Strategy and Financial Analysis
  • STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Haemonetics Corporation
• Macopharma
• Discovery Life Sciences
• BioIVT LLC
• StemExpress LLC
• MEDICA S.p.A
• AllCells LLC
• Caltag Medsystems Ltd.
• Miltenyi Biotec
• Immune Therapy Holdings AB
• Cellsep Laboratories
• Accegen Biotec
• Key Biologics LLC
• HemaCare Corporation
• Puriblood Medical

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 白血球除去療法市場2029年：新たな機会を提供する国
• 白血球除去療法市場2029年：新たな機会を提供するセグメント
• 白血球除去療法市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Leukapheresis is a medical procedure that involves the separation and removal of white blood cells (leukocytes) from a patient's blood. The remaining blood components, such as red blood cells and plasma, are then returned to the body. This technique is used to treat conditions with elevated white blood cell counts or to collect specific immune cells for research or therapeutic purposes.

The main types of leukapheresis include granulocyte, lymphocyte, and monocyte apheresis. Granulocyte apheresis is a procedure that selectively isolates granulocytes (a type of white blood cell) from a patient's blood for therapeutic use. Products related to this procedure include leukapheresis devices, centrifugal devices, membrane separators, and disposables. Applications of leukapheresis extend to research areas such as cancer research, immunology, hematologic disorders, autoimmune diseases, and others. These procedures are utilized by blood component providers, blood centers, academic and research institutions, pharmaceutical and biotechnology companies, and hospitals and transfusion centers.

The leukapheresis market research report is one of a series of new reports from The Business Research Company that provides leukapheresis market statistics, including the leukapheresis industry global market size, regional shares, competitors with the leukapheresis market share, detailed leukapheresis market segments, market trends, and opportunities, and any further data you may need to thrive in the leukapheresis industry. This leukapheresis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The leukapheresis market size has grown strongly in recent years. It will grow from $66.80 billion in 2024 to $72.23 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. Growth during the historic period can be attributed to the increasing prevalence of leukemia and autoimmune diseases, rising demand for personalized medicine, advancements in stem cell research, improvements in apheresis technologies, expanding clinical trial activities, and greater awareness of immunotherapy applications.

The leukapheresis market size is expected to see strong growth in the next few years. It will grow to $97.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. Growth in the forecast period is expected to be driven by rising demand for personalized cell therapies, an increase in clinical trials in immuno-oncology, growing adoption in regenerative medicine, expansion of biopharmaceutical manufacturing, improved reimbursement policies, and greater awareness of cell-based research and treatment options. Key trends in the forecast period include advancements in cell separation technologies, integration of AI for optimizing procedures, development of portable leukapheresis devices, progress in cell and gene therapy, enhanced donor screening methods, and the adoption of cloud-based data tracking systems.

The growing incidence of autoimmune diseases is anticipated to drive the expansion of the leukapheresis market. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy tissues. Factors such as reduced early-life microbial exposure and modern environmental influences are disrupting immune balance, leading to an increase in autoimmune disorders. Leukapheresis aids in treating these diseases by selectively removing harmful white blood cells that contribute to the immune system's attack on the body. For example, according to a report by Versorgungsatlas.de, a Germany-based organization, in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a prevalence rate of 8.61%. Thus, the rise in autoimmune diseases is fueling the growth of the leukapheresis market.

Leading companies in the leukapheresis market are focusing on innovations such as the development of GMP-grade leukopaks to improve the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are leukapheresis-derived products processed under stringent good manufacturing practice (GMP) standards, ensuring high cell viability and functionality for therapeutic use. For instance, in November 2024, Sanguine Biosciences, a US-based biotechnology company, introduced LeukoCer, a GMP-grade leukopak designed to streamline workflows and speed up cell therapy development. LeukoCer provides high-quality starting materials in fresh whole or half packs, produced according to strict GMP standards, enabling researchers to advance their work and accelerate the introduction of new cell therapies to the market.

In July 2023, SCTbio, a Czech Republic-based contract development and manufacturing organization, formed a partnership with Cyto-care.eu GmbH to enhance the cryopreservation process for cell therapy in Europe. The collaboration focuses on improving the collection, cryopreservation, quality control, and logistics of leukapheresis materials, which are vital components in the production of advanced cell therapy products (ATMPs). Cyto-care.eu GmbH, based in Austria, specializes in providing cell products for biomedical research, drug discovery, and cell and gene therapy.

Major players in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., STEMCELL Technologies Inc., Haemonetics Corporation, Macopharma, Discovery Life Sciences, BioIVT LLC, StemExpress LLC, MEDICA S.p.A, AllCells LLC, Caltag Medsystems Ltd., Miltenyi Biotec, Immune Therapy Holdings AB, Cellsep Laboratories, Accegen Biotec, Key Biologics LLC, HemaCare Corporation, Puriblood Medical, Cytopheron Technologies, and Adacyte Therapeutics.

North America was the largest region in the leukapheresis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in leukapheresis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the leukapheresis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leukapheresis market consists of revenues earned by entities providing services such as cell collection, cell processing and storage, and custom apheresis procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The leukapheresis market also includes sales of products such as apheresis machines, centrifugal and membrane-based systems, needles & catheters, and anticoagulants and solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukapheresis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on leukapheresis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukapheresis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The leukapheresis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Granulocyte Apheresis; Lymphocyte Apheresis; Monocyte Apheresis
• 2) By Product: Leukapheresis Devices; Centrifugal Devices; Membrane Separators; Leukapheresis Disposables
• 3) By Application: Research Application; Cancer Research; Immunology Research; Therapeutics Application; Hematologic Disorders; Autoimmune Diseases; Other Applications
• 4) By End User: Blood Component Providers And Blood Centers; Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Transfusion Centers
• Subsegments:
• 1) By Granulocyte Apheresis: Neutrophil Apheresis; Eosinophil Apheresis; Basophil Apheresis
• 2) By Lymphocyte Apheresis: T-Cell Apheresis; B-Cell Apheresis; Natural Killer (NK) Cell Apheresis
• 3) By Monocyte Apheresis: Classical Monocytes; Non-Classical Monocytes; Intermediate Monocytes
• Companies Mentioned: Fresenius Kabi; Grifols S.A.; Terumo BCT Inc.; Nikkiso Co.; STEMCELL Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Leukapheresis Market Characteristics

3. Leukapheresis Market Trends And Strategies

4. Leukapheresis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Leukapheresis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Leukapheresis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Leukapheresis Market Growth Rate Analysis
• 5.4. Global Leukapheresis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Leukapheresis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Leukapheresis Total Addressable Market (TAM)

6. Leukapheresis Market Segmentation

• 6.1. Global Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Granulocyte Apheresis
• Lymphocyte Apheresis
• Monocyte Apheresis
• 6.2. Global Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukapheresis Devices
• Centrifugal Devices
• Membrane Separators
• Leukapheresis Disposables
• 6.3. Global Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Application
• Cancer Research
• Immunology Research
• Therapeutics Application
• Hematologic Disorders
• Autoimmune Diseases
• Other Applications
• 6.4. Global Leukapheresis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Component Providers And Blood Centers
• Academic And Research Institutes
• Pharmaceutical And Biotechnology Companies
• Hospitals And Transfusion Centers
• 6.5. Global Leukapheresis Market, Sub-Segmentation Of Granulocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neutrophil Apheresis
• Eosinophil Apheresis
• Basophil Apheresis
• 6.6. Global Leukapheresis Market, Sub-Segmentation Of Lymphocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• T-Cell Apheresis
• B-Cell Apheresis
• Natural Killer (NK) Cell Apheresis
• 6.7. Global Leukapheresis Market, Sub-Segmentation Of Monocyte Apheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Classical Monocytes
• Non-Classical Monocytes
• Intermediate Monocytes

7. Leukapheresis Market Regional And Country Analysis

• 7.1. Global Leukapheresis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Leukapheresis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leukapheresis Market

• 8.1. Asia-Pacific Leukapheresis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leukapheresis Market

• 9.1. China Leukapheresis Market Overview
• 9.2. China Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leukapheresis Market

• 10.1. India Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leukapheresis Market

• 11.1. Japan Leukapheresis Market Overview
• 11.2. Japan Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leukapheresis Market

• 12.1. Australia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leukapheresis Market

• 13.1. Indonesia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leukapheresis Market

• 14.1. South Korea Leukapheresis Market Overview
• 14.2. South Korea Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leukapheresis Market

• 15.1. Western Europe Leukapheresis Market Overview
• 15.2. Western Europe Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leukapheresis Market

• 16.1. UK Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leukapheresis Market

• 17.1. Germany Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leukapheresis Market

• 18.1. France Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leukapheresis Market

• 19.1. Italy Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leukapheresis Market

• 20.1. Spain Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leukapheresis Market

• 21.1. Eastern Europe Leukapheresis Market Overview
• 21.2. Eastern Europe Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leukapheresis Market

• 22.1. Russia Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leukapheresis Market

• 23.1. North America Leukapheresis Market Overview
• 23.2. North America Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leukapheresis Market

• 24.1. USA Leukapheresis Market Overview
• 24.2. USA Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leukapheresis Market

• 25.1. Canada Leukapheresis Market Overview
• 25.2. Canada Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leukapheresis Market

• 26.1. South America Leukapheresis Market Overview
• 26.2. South America Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leukapheresis Market

• 27.1. Brazil Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leukapheresis Market

• 28.1. Middle East Leukapheresis Market Overview
• 28.2. Middle East Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leukapheresis Market

• 29.1. Africa Leukapheresis Market Overview
• 29.2. Africa Leukapheresis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leukapheresis Market Competitive Landscape And Company Profiles

• 30.1. Leukapheresis Market Competitive Landscape
• 30.2. Leukapheresis Market Company Profiles
  • 30.2.1. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Terumo BCT Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Nikkiso Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Leukapheresis Market Other Major And Innovative Companies

• 31.1. Haemonetics Corporation
• 31.2. Macopharma
• 31.3. Discovery Life Sciences
• 31.4. BioIVT LLC
• 31.5. StemExpress LLC
• 31.6. MEDICA S.p.A
• 31.7. AllCells LLC
• 31.8. Caltag Medsystems Ltd.
• 31.9. Miltenyi Biotec
• 31.10. Immune Therapy Holdings AB
• 31.11. Cellsep Laboratories
• 31.12. Accegen Biotec
• 31.13. Key Biologics LLC
• 31.14. HemaCare Corporation
• 31.15. Puriblood Medical

32. Global Leukapheresis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leukapheresis Market

34. Recent Developments In The Leukapheresis Market

35. Leukapheresis Market High Potential Countries, Segments and Strategies

• 35.1 Leukapheresis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Leukapheresis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Leukapheresis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer